HomeInsightsStock Comparison

Coral Laboratories Ltd vs Kwality Pharmaceuticals Ltd Stock Comparison

Coral Laboratories Ltd vs Kwality Pharmaceuticals Ltd Stock Comparison

Last Updated on: Sep 08, 2025

Key Highlights

  • The Latest Trading Price of Coral Laboratories Ltd is ₹ 503.15 as of 08 Sep 15:30.
  • The P/E Ratio of Coral Laboratories Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Kwality Pharmaceuticals Ltd changed from 3.2 on March 2020 to 22.6 on March 2025 . This represents a CAGR of 38.51% over 6 years.
  • The Market Cap of Coral Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Kwality Pharmaceuticals Ltd changed from ₹ 26.51 crore on March 2020 to ₹ 901.74 crore on March 2025 . This represents a CAGR of 80.00% over 6 years.
  • The revenue of Coral Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Kwality Pharmaceuticals Ltd for the Jun '25 is ₹ 111.85 crore as compare to the Mar '25 revenue of ₹ 116.44 crore. This represent the decline of -3.94%.
  • The ebitda of Coral Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Kwality Pharmaceuticals Ltd for the Jun '25 is ₹ 24.55 crore as compare to the Mar '25 ebitda of ₹ 26.65 crore. This represent the decline of -7.88%.
  • The net profit of Coral Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Kwality Pharmaceuticals Ltd changed from ₹ 5.4 crore to ₹ 11.92 crore over 9 quarters. This represents a CAGR of 42.18% .
  • The Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kwality Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Coral Laboratories Ltd

  • Coral Laboratories Limited (CLL) was established in February, 1997.
  • Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.
  • The Company produces various pharmaceutical formulations in 3 different locations all over India.
  • It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group.
  • To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company went into public issue in March 94 at a total cost of Rs.2.5 crores.

About Kwality Pharmaceuticals Ltd

  • Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics.
  • With little background of finished pharmaceuticals and high held spirits and will, he started this business.
  • He received his first drug license in 1981 approved for liquid oral manufacturing.
  • Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables.
  • The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce.

Coral Laboratories Ltd News Hub

News

Coral Laboratories schedules AGM

Coral Laboratories announced that the 43th Annual General Meeting(AGM) of the company will...

Read more

30 Aug 2025 15:51

News

Coral Laboratories to convene board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 Augu...

Read more

08 Aug 2025 17:49

News

Board of Coral Laboratories recommends final dividend

Coral Laboratories announced that the Board of Directors of the Company at its meeting hel...

Read more

31 May 2025 14:48

News

Coral Laboratories schedules board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 30 May ...

Read more

23 May 2025 20:23

News

Coral Laboratories announces board meeting date

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 Febr...

Read more

06 Feb 2025 13:39

News

Coral Laboratories schedules board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

08 Nov 2024 17:38

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharmaceuticals to conduct AGM

Kwality Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will...

Read more

19 Aug 2025 10:40

News

KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico

Kwality Pharmaceutical has received registration for Bleomycin 15 IU in Mexico for sale an...

Read more

18 Aug 2025 12:05

News

Kwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico

According to an exchange filing, Bleomycin is a widely used anti-cancer medicine, effectiv...

Read more

18 Aug 2025 14:05

News

Kwality Pharmaceuticals schedules board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11...

Read more

05 Aug 2025 18:12

News

Kwality Pharma spurts on strong Q4 numbers

Sequentially, the company's consolidated net profit surged 69.87% while net sales jumped 3...

Read more

20 May 2025 16:17

News

Kwality Pharmaceuticals to declare Quarterly Results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 19...

Read more

08 May 2025 11:18

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Coral Laboratories Ltd

Strength

3

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Kwality Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Coral Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Coral Laboratories Ltd and Kwality Pharmaceuticals Ltd

Which company has a larger market capitalization, Coral Laboratories Ltd or Kwality Pharmaceuticals Ltd?

Market cap of Coral Laboratories Ltd is 179 Cr while Market cap of Kwality Pharmaceuticals Ltd is 981 Cr

What are the key factors driving the stock performance of Coral Laboratories Ltd and Kwality Pharmaceuticals Ltd?

The stock performance of Coral Laboratories Ltd and Kwality Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Coral Laboratories Ltd and Kwality Pharmaceuticals Ltd?

As of September 8, 2025, the Coral Laboratories Ltd stock price is INR ₹503.15. On the other hand, Kwality Pharmaceuticals Ltd stock price is INR ₹946.35.

How do dividend payouts of Coral Laboratories Ltd and Kwality Pharmaceuticals Ltd compare?

To compare the dividend payouts of Coral Laboratories Ltd and Kwality Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions